ANNOVATION BIOPHARMA, INC.

Profile

Company Names

ANNOVATION BIOPHARMA, INC.

Addresses

C/O ATLAS VENTURE, 25 FIRST STREET, SUITE 303, CAMBRIDGE, MA 02141

C/O ATLAS VENTURE FUND VIII, L.P., 25 FIRST STREET, SUITE 303, CAMBRIDGE, MA 02141

Phone Numbers

617-588-2600

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$8,375,201.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2012-07-23 
$8,000,201.00 
$11,000,201.00 
$3,000,000.00 
Equity 
1
2011-05-02 
$375,000.00 
$750,000.00 
$375,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NICHOLAS 
 
BARKER 
DIRECTOR
ANNOVATION BIOPHARMA, INC.
CARL 
 
BERKE 
EXECUTIVE OFFICER, DIRECTOR
COMBINENT BIOMEDICAL SYSTEMS, INC.   |  ANNOVATION BIOPHARMA, INC.   |  INFOBIONIC, INC.   |  QPID, INC.   |  PARTNERS INNOVATION FUND II, L.P.   |  PYKUS THERAPEUTICS, INC.
JASON 
 
CAMPAGNA 
DIRECTOR
ANNOVATION BIOPHARMA, INC.
JEAN-FRANCOIS 
 
FORMELA 
DIRECTOR
ARCA BIOPHARMA, INC.   |  RESOLVYX PHARMACEUTICALS, INC.   |  HORIZON PHARMA, INC.   |  ANNOVATION BIOPHARMA, INC.   |  ARTEAUS THERAPEUTICS, LLC   |  COSTIM PHARMACEUTICALS INC.   |  CALORICS, INC.   |  NAVITOR PHARMACEUTICALS, INC.   |  INTELLIA THERAPEUTICS, INC.   |  IFM THERAPEUTICS, INC.   |  SPERO THERAPEUTICS, LLC   |  ATLAS VENTURE FUND XI, L.P.   |  IFM TRE, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  TRANSLATE BIO, INC.   |  KORRO BIO, INC.   |  IFM QUATTRO, INC.   |  IFM CINQUE, INC.   |  IFM CONTINUA, INC.   |  ATLAS VENTURE FUND XII, L.P.   |  SCORPION THERAPEUTICS, INC.   |  SPERO THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  AMAGMA, INC.   |  IKENA ONCOLOGY, INC.   |  ANTARES THERAPEUTICS, INC.
DAVID 
 
GRAYZEL 
EXECUTIVE OFFICER, DIRECTOR
ANNOVATION BIOPHARMA, INC.   |  ARTEAUS THERAPEUTICS, LLC   |  ATLAS VENTURE FUND XI, L.P.   |  AKRIVEIA THERAPEUTICS, LLC   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  AFFINIA THERAPEUTICS INC.   |  ATLAS VENTURE FUND XII, L.P.   |  AEROVATE THERAPEUTICS, INC.   |  XILIO THERAPEUTICS, INC.   |  SANTI THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  TRIANA BIOMEDICINES, INC.   |  ATLAS VENTURE FUND XIII, L.P.   |  COMANCHE BIOPHARMA CORP.   |  ATLAS VENTURE FUND XIV, L.P.
ANKIT 
 
MAHADEVIA 
DIRECTOR
RANA THERAPEUTICS, INC.   |  ANNOVATION BIOPHARMA, INC.   |  SYNLOGIC, INC.   |  SYNLOGIC, LLC   |  SPERO THERAPEUTICS, LLC   |  SPERO THERAPEUTICS, INC.   |  JUDO BIO INC.   |  ANTLIA BIOSCIENCE, INC.
DOUGLAS 
 
RAINES 
DIRECTOR
ANNOVATION BIOPHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-04-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-23 
2012-07-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-23 
2011-05-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#